Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12873199 | 0.97 | HPGD (0.38) | HPGDALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL12873198 | 0.89 | HPGD (0.40) | HPGD | |
| SCHEMBL13008985 | 0.89 | HSP90AA1 (0.36) | HPGDALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL13009021 | 0.89 | CYP1A2 (0.39) | HPGDALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL13009390 | 0.89 | HSP90AA1 (0.36) | HPGDALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL13428311 | 0.89 | CYP1A2 (0.39) | HPGDALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL12873197 | 0.88 | HPGD (0.33) | HPGD | |
| SCHEMBL13428138 | 0.88 | CYP1A2 (0.37) | HPGDALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL13009395 | 0.88 | HPGD (0.35) | HPGDALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL13008787 | 0.88 | HPGD (0.35) | HPGDALDH1A1LMNACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9045419-B2 | Condensed-cyclic compound and organic light emitting diode having organic layer including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-06-02 | — | — | US | disclosed |
| US-9045419-B2 | Condensed-cyclic compound and organic light emitting diode having organic layer including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-06-02 | — | — | US | disclosed |
| US-20110031484-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE HAVING ORGANIC LAYER INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-02-10 | — | — | US | disclosed |
| US-20110031484-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE HAVING ORGANIC LAYER INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110031484-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE HAVING ORGANIC LAYER INCLUDING THE SAME | CRY1, CCNL2, CCNT1 | HPGD 2260/4885ALDH1A1 153/4885LMNA 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.